Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre

This is the latest version of this eprint.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Kabia, A, Darby, M et al. (5 more authors) (2017) Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre. Rheumatology, 56 (8). pp. 1348-1357. ISSN 1462-0324

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017, The Author. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. This is a pre-copyedited, author-produced PDF of an article accepted for publication in Rheumatology following peer review. The version of record, 'Md Yuzaiful Md Yusof, Angela Kabia, Michael Darby, Giovanni Lettieri, Paul Beirne, Edward M. Vital, Shouvik Dass, Paul Emery; Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre, Rheumatology, Volume 56, Issue 8, 1 August 2017, Pages 1348–1357,' is available online at: https://doi.org/10.1093/rheumatology/kex072.
Keywords: B cells, biologic therapies, immunosuppressant, respiratory, rheumatoid arthritis
Dates:
  • Published: 1 August 2017
  • Accepted: 21 February 2017
  • Published (online): 24 April 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 02 May 2017 11:07
Last Modified: 24 Apr 2018 00:38
Published Version: https://doi.org/10.1093/rheumatology/kex072
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kex072
Related URLs:

Available Versions of this Item

Share / Export

Statistics